IP Verse

Bayer Pharma Ag V. Teva Pharmaceuticals Usa, Inc. - 1:23-cv-00551

Explore the details of the Bayer Pharma Ag V. Teva Pharmaceuticals Usa, Inc. case under case number 1:23-cv-00551 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
1:23-cv-00551
Filing Date
May 19, 2023
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

Parties Involved in the Case

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Janssen Pharmaceuticals, Inc. -
Teva Pharmaceuticals USA, Inc. -
Bayer Pharma AG -

Patents Involved in the Case

Patents not found - set an alert to get notified when patents are added.

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Jul 12, 2023SUMMONS Returned Executed by Bayer Pharma AG, Janssen Pharmaceuticals, Inc., Bayer AG.Teva Pharmaceuticals USA, Inc. served on 7/12/2023, answer due 8/2/2023. (Fahnestock, Derek) (Entered: 07/12/2023)PACER Document
Jul 26, 2023STIPULATION Dismissing Teva Pharmaceutical Industries Ltd., by Teva Pharmaceuticals USA, Inc.. (Keller, Karen) Modified on 7/26/2023 (nms). (Entered: 07/26/2023)PACER Document
Jul 27, 2023SO ORDERED Granting 9 Stipulation Dismissing Teva Pharmaceutical Industries Ltd.. Signed by Judge Richard G. Andrews on 7/27/2023. (nms) (Entered: 07/27/2023)PACER Document
Aug 9, 2023STIPULATION and Order to Extend Time - filed by Teva Pharmaceuticals USA, Inc.. (Keller, Karen) Modified on 8/9/2023 (nms). (Entered: 08/09/2023)PACER Document
Aug 14, 2023Joint Status Report, by Teva Pharmaceuticals USA, Inc.. (Keller, Karen) Modified on 8/15/2023 (nms). (Entered: 08/14/2023)PACER Document
Sep 1, 2023Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Teva Pharmaceuticals Ltd for Teva Pharmaceuticals USA, Inc. filed by Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) (Entered: 09/01/2023)PACER Document
Sep 1, 2023ANSWER to 1 Complaint, and COUNTERCLAIMS against all Plaintiffs, by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) Modified on 9/5/2023 (nms). (Entered: 09/01/2023)PACER Document
Sep 15, 2023STIPULATION and [Proposed] Order Regarding Consolidation and Schedule - by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) (Entered: 09/15/2023)PACER Document
Sep 15, 2023SO ORDERED Granting (D.I. 188 in 21-md-3017-RGA; D.I. 16 in 23-cv-551-RGA; D.I. 154 in 21-cv-314-RGA-JLH) Stipulation and Proposed Order Regarding Consolidation and Schedule. Signed by Judge Richard G. Andrews on 9/15/2023. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:23-cv-00551-RGA(nms) (Entered: 09/15/2023)PACER Document
May 19, 2023Remark: MDL panel has been advised. (mkr)PACER Document
May 24, 2023Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:23-cv-00551-RGA, 1:23-cv-00556-RGA (rjb)PACER Document
Aug 9, 2023ORAL ORDER: An answer was due to be filed on 8/2/2023 (see D.I. 8 ), and to date none has been filed. A joint status letter is now due no later than three (3) days from the entry of this Order. Ordered by Judge Richard G. Andrews on 8/9/2023. (nms) (Entered: 08/09/2023)PACER Document
Aug 9, 2023SO ORDERED, re 12 STIPULATION and Order to Extend Time (*Reset Answer Deadlines: Teva Pharmaceuticals USA, Inc. answer due 9/1/2023). Signed by Judge Richard G. Andrews on 8/9/2023. (nms)PACER Document
Sep 25, 2023CORRECTING ENTRY: The Answer filed at D.I. 18 on 9/22/2023, has been removed from the docket. All filings are to be docketed in Lead Civil Action 21cv314-RGA-JLH and 21md3017-RGA ONLY (see D.I. 17 ). (nms)PACER Document